Adaptimmune Therapeutics plc (ADAP): Price and Financial Metrics
ADAP Price/Volume Stats
| Current price | $0.58 | 52-week high | $2.05 |
| Prev. close | $0.59 | 52-week low | $0.53 |
| Day low | $0.57 | Volume | 621,500 |
| Day high | $0.59 | Avg. volume | 1,602,591 |
| 50-day MA | $0.65 | Dividend yield | N/A |
| 200-day MA | $0.96 | Market Cap | 148.39M |
ADAP Stock Price Chart Interactive Chart >
Adaptimmune Therapeutics plc (ADAP) Company Bio
Adaptimmune Therapeutics plc is a clinical stage biopharmaceutical company focused on novel cancer immunotherapy products based on its T-cell receptor platform. The company was founded in 2014 and is based in Abingdon, the United Kingdom.
ADAP Price Returns
| 1-mo | -4.12% |
| 3-mo | -26.11% |
| 6-mo | -55.38% |
| 1-year | -20.14% |
| 3-year | -79.93% |
| 5-year | -85.61% |
| YTD | 7.67% |
| 2024 | -32.07% |
| 2023 | -45.68% |
| 2022 | -61.07% |
| 2021 | -30.43% |
| 2020 | 349.17% |
Continue Researching ADAP
Here are a few links from around the web to help you further your research on Adaptimmune Therapeutics PLC's stock as an investment opportunity:Adaptimmune Therapeutics PLC (ADAP) Stock Price | Nasdaq
Adaptimmune Therapeutics PLC (ADAP) Stock Quote, History and News - Yahoo Finance
Adaptimmune Therapeutics PLC (ADAP) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...